Zachary R. Blume

Business Combination Transactions

• Represented The L.S. Starrett Company in its sale to MiddleGround Capital.
• Represented TravelCenters of America in its $1.3 billion sale to BP.
• Represented GI Partners in its acquisition of Atlas Technical Consultants.
• Represented Wright Medical N.V. in its $5.4 billion sale to Stryker.
• Represented Radius Health in its sale to Gurnet Point Capital and Patient Square Capital.
• Represented a special committee of the board of Akcea Therapeutics in connection with the sale of Akcea to Ionis Pharmaceuticals.
• Represented a special committee of the board of AlerisLife Inc. in connection with AlerisLife's sale to ABP Acquisition.
• Represented Galderma in its acquisition of ALASTIN Skincare and sale of Alchemee.
• Represented Shire in its $32 billion combination with Baxalta for a combination of cash and stock and its acquisition of Dyax Corporation for $5.9 billion in cash plus contingent value rights.
• Represented NxStage Medical in its $2 billion sale to Fresenius Medical Care Holdings.
• Represented Town Fair Tire in its sale to Mavis Tire Express Services.
• Represented Max Finkelstein, Inc. in its sale to U.S. AutoForce. 
• Represented HiberCell in its acquisition of Genuity Science.
• Represented Vertex Pharmaceuticals in its acquisition of Exonics Therapeutics.
• Represented Visterra, Inc. in its sale to Otsuka Pharmaceutical. 
• Represented Novanta Inc. in its acquisition of ATI Industrial Automation.
• Represented Alexion Pharmaceuticals Corp. in its acquisitions of Wilson Therapeutics and Enobia Pharma Corp.
• Represented Champion Enterprises Holdings in its business combination transaction with Skyline Corporation.
• Represented Cubist Pharmaceuticals in its sale to Merck for $9.5 billion and in its simultaneously announced acquisitions of Optimer Pharmaceuticals, Inc. and Trius Therapeutics, Inc. for cash and contingent value rights valued at $801 million and $818 million, respectively. 
• Represented Multi Packaging Solutions International Limited in its $2.3 billion sale to WestRock Company.
• Represented Genzyme Corporation in its sale to Sanofi for $20.1 billion in cash plus contingent value rights.
• Represented Entegris, Inc. in its $1.15 billion acquisition of ATMI, Inc.
• Represented Reebok International Ltd. in its sales of The Rockport Company and Mitchell & Ness.
• Represented Timberland Company in its $2.23 billion sale to V.F. Corporation.
• Represented Synageva BioPharma Corp. in its acquisition, through a reverse merger, of Trimeris, Inc.

Capital Markets Transactions

• Represented Rallybio in its $92 million initial public offering and subsequent follow-on equity offering.
• Represented MiNK Therapeutics in its initial public offering. 
• Represented Blackstone Life Sciences in strategic financing collaborations with Alnylam, PTC Therapeutics and Harmony Biosciences.
• Represented The Hanover Insurance Group in multiple registered offerings of senior notes.
• Represented Skyline Champion Corporation and the selling shareholders in follow-on offerings with total proceeds in excess of $800 million.
• Represented Synageva BioPharma Corp. in follow-on offerings with total proceeds of over $750 million.
• Represented Aegerion Pharmaceuticals in its issuance of $350 million of convertible notes.
• Represented the underwriters in a $750 million convertible note offering by Incyte Corporation.
• Represented the underwriters in the IPOs of bluebird bio, Inc. and Foundation Medicine, Inc., as well as several follow-on equity offerings.